Genetic manipulation of Clostridium difficile
- PMID: 21400677
- PMCID: PMC3615975
- DOI: 10.1002/9780471729259.mc09a02s20
Genetic manipulation of Clostridium difficile
Abstract
Clostridium difficile is a Gram-positive, spore forming, anaerobic, intestinal bacterium and is the most common cause of antibiotic-associated colitis. For many years this organism was considered genetically intractable, but in the past 10 years, multiple methods have been developed or adapted for genetic manipulation of C. difficile. This unit describes the molecular techniques used for genetic modification of this organism, including methods for gene disruption, complementation, plasmid introduction and integration, and cross-species conjugations.
© 2011 by John Wiley & Sons, Inc.
References
-
- Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 1977;136:701–705. - PubMed
-
- Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978;75:778–782. - PubMed
-
- Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 2007;66:206–219. - PubMed
-
- Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol. Microbiol. 1998;27:107–120. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources